/Companies

Vico Therapeutics

9 known investors

Find your way into Vico Therapeutics

Sign up to see every warm intro you have to Vico Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Vico Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Vico Therapeutics develops targeted genetic medicines for neurological disorders, with a focus on antisense oligonucleotide therapies designed to address the underlying genetic causes of diseases like Huntington's disease and spinocerebellar ataxias.

Founders & leadership

LDLuc Dochez
Luc DochezChair and FounderManaging Partner at Droia Ventures
JMJosh Mandel-Brehm
Josh Mandel-BrehmCo-FounderExecutive Officer, Director at Camp4 Therapeutics Corp

Investors · 9

Also in the syndicate · 1

Ackermans & van Haarenlead

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Founder mafia

2 people who came through Vico Therapeutics went on to found or lead other companies.

In the news

Frequently asked questions

What does Vico Therapeutics do?
Vico Therapeutics develops targeted genetic medicines for neurological disorders, with a focus on antisense oligonucleotide therapies designed to address the underlying genetic causes of diseases like Huntington's disease and spinocerebellar ataxias.
Who founded Vico Therapeutics?
Vico Therapeutics was founded by Luc Dochez, Josh Mandel-Brehm.
Who are Vico Therapeutics's investors?
Vico Therapeutics's investors include Droia Ventures, Kurma Partners, Pureos Bioventures, EQT Life Sciences, Seroba Life Sciences, Eurazeo, Idinvest Partners, Polaris Partners.